ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀ忹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ³²¼º ¼º¼± ±â´É ÀúÇÏÁõ ½ÃÀå
Male Hypogonadism
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 4,950
£Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¿¥Æı۸®Ç÷ÎÁø, ´ÙÆı۸®Ç÷ÎÁø, Ä«³ª±Û¸®Ç÷ÎÁø ½ÃÀå º¸°í¼(2024³â)
Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,000
£Ü 6,795,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ±º¹ßµÎÅëÁõÈıº ½ÃÀå º¸°í¼(2024³â)
Cluster Headache Syndrome Global Market Report 2024
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,000
£Ü 6,795,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå
West Nile Virus
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,600
£Ü 7,610,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÄÚ Æú¸³À» µ¿¹ÝÇÑ ¸¸¼º ºñºÎºñµ¿¿° ½ÃÀå º¸°í¼(2024³â)
Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2024
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,000
£Ü 6,795,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°è ÇǺΠ¹× Àü½Å ¸®½´¸¶´Ï¾îÁõ ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Cutaneous and Systemic Leishmaniasis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,900
£Ü 6,659,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¼öÀ弶À¯Á¾Áõ ½ÃÀå(2024-2031³â)
Global Palmar Fibromatosis Market - 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,350
£Ü 5,911,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ °£¼¼Æ÷ ¼ºÀå ÀÎÀÚ(HGFs) ½ÃÀå : ½ÃÀå ±Ô¸ð-À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Hepatocyte Growth Factors Market Size Study, by Type (Phase III, Phase II, Phase II, Phase I, Preclinical) by Application by End-User and Regional Forecasts 2022-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,950
£Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
|
·¹º£¸£ ¼±Ãµ¼º Èæ¾Ï½Ã ½ÃÀå : Ä¡·á À¯Çüº°, Ç¥Àû À¯ÀüÀÚº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Leber Congenital Amaurosis Market, By Treatment Type, By Target Gene, By End User, By Geography
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,500
£Ü 6,115,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°è ³ó°¡Áø Ä¡·áÁ¦ ½ÃÀå
Impetigo Drugs
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,406,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ½Â¸ðÆǸ· Áúȯ ½ÃÀå º¸°í¼(2024³â)
Mitral Valve Disease Global Market Report 2024
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,000
£Ü 6,795,000 (ºÎ°¡¼¼ º°µµ)
|
¿åâ Ä¡·á ½ÃÀå º¸°í¼ : ±Ë¾ç À¯Çü, Á¦Ç° À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)
Pressure Ulcers Treatment Market Report by Ulcer Type, Product Type, End User, and Region 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 3,899
£Ü 5,298,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ GLP-1 À¯»çü ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç°º°, Á¦Çüº°, Åõ¿© °æ·Îº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global GLP-1 Analogues Market Size study, by Product, by Format, by Route of Administration, by Indication, by End User and Regional Forecasts 2022-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,950
£Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀÌÁú±Õ °Ë»ç Å°Æ® ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, °Ë»ç À¯Çüº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2019-2029³â)
Shigella Test Kit Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End User, By Region and Competition, 2019-2029F
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,900
£Ü 6,659,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¸ô¸®ºêµ§ º¸Á¶ÀÎÀÚ °áÇÌÁõ AÇü(MoCoD-A) ½ÃÀå - ÀλçÀÌÆ®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(2034³â)
Molybdenum Cofactor Deficiency Type-A (MoCoD-A) - Market Insights, Epidemiology, and Market Forecast-2034
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 7,950
£Ü 10,804,000 (ºÎ°¡¼¼ º°µµ)
|
Ⱦ¹®±ÙÀ°Á¾ ½ÃÀå - ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2024³â)
Rhabdomyosarcoma - Global Clinical Trials Review, 2024
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 3,450
£Ü 4,688,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ °íÁß¼ºÁö¹æÇ÷Áõ(HTG) ½ÃÀå ÆÄÀÌÇÁ¶óÀÎ
Global Hypertriglyceridemia Market Pipeline
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 2,900
£Ü 3,941,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Èí¼öºÒ·®ÁõÈıº ½ÃÀå(2024-2028³â)
Global Malabsorption Syndrome Market 2024-2028
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 2,500
£Ü 3,397,000 (ºÎ°¡¼¼ º°µµ)
|
Æ®·ç¸®½ÃƼ(Trulicity) : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)
Trulicity - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,750
£Ü 6,455,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ³²¼º ¼º¼±±â´ÉÀúÇÏÁõ ½ÃÀå(2024-2028³â)
Global Male Hypogonadism Market 2024-2028
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 2,500
£Ü 3,397,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ GLP-1 ¾Æ³¯·Î±× ½ÃÀå : Á¦Ç°º°, Çü½Äº°, Åõ¿© °æ·Îº°, ÀûÀÀÁõº° - ¿¹Ãø(-2032³â)
GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose, Tablets), ROA (Subcutaneous, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2032
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,950
£Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
|
¼¶À¯¾Æ¼¼Æ÷ ¼ºÀåÀÎÀÚ ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2033³â)
Fibroblast Growth Factors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,900
£Ü 6,659,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ½ÅÁõÈıº Ä¡·áÁ¦ ½ÃÀå(2024-2031³â)
Global Nephrotic Syndrome Drugs Market - 2024-2031
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,350
£Ü 5,911,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ È£»ê±¸Áõ°¡Áõ ½ÃÀå(2024-2031³â)
Global Eosinophilic Disorder Market - 2024-2031
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,350
£Ü 5,911,000 (ºÎ°¡¼¼ º°µµ)
|
GLP-1 ½ÃÀå : »ê¾÷ µ¿Çâ ¹× ¼¼°è Àü¸Á(-2035³â) - ºÐÀÚ À¯Çüº°, »ç¿ë È°¼º ÈÇÕ¹°º°, GLP-1 ÀÛ¿ëÁ¦ À¯Çüº°, GLP-1 ÀÛ¿ëÁ¦º°, Åõ¿© °æ·Îº°, Ç¥Àû ÀûÀÀÁõº°, Áö¿ªº°, ÁÖ¿ä Á¦¾à»çº°, ¸ÅÃâ ¿¹Ãø
GLP-1 Market: Industry Trends and Global Forecasts, till 2035 Distribution by Type of Molecule, Active Compound Used, Route of Administration, Target indication, Geography, Leading Drug Developers and Sales Forecast
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,799
£Ü 6,521,000 (ºÎ°¡¼¼ º°µµ)
|